Gene Therapy Manufacturing Hitch Solved, Bluebird Aims For European Debut In 2020
First Treatment Expected In Germany
Executive Summary
The EMA has declared itself satisfied with ‘refined manufacturing specifications’ for the beta thalassemia treatment